Private Advisor Group, LLC Gilead Sciences, Inc. Transaction History

Private Advisor Group, LLC

$17.4 Billion
Q4 2024

A detailed history of Private Advisor Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 34,682 shares of GILD stock, worth $3.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

34,682

Previous 37,646 7.87%

Holding current value

$3.31 Million

Previous $3.16 Million 1.52%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$83.95 - $97.9 $248,827 - $290,175	-2,964 Reduced 7.87%	34,682 $3.2 Million
Q3 2024 Oct 22, 2024	SELL	$66.59 - $83.99 $385,822 - $486,638	-5,794 Reduced 13.34%	37,646 $3.16 Million
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $66,623 - $76,888	-1,055 Reduced 2.37%	43,440 $2.98 Million
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $716,873 - $874,209	-10,015 Reduced 18.37%	44,495 $3.26 Million
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $111,736 - $126,712	1,525 Added 2.88%	54,510 $4.42 Million
Q3 2023 Nov 02, 2023	SELL	$73.94 - $80.67 $240,378 - $262,258	-3,251 Reduced 5.78%	52,985 $3.97 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $142,214 - $162,215	1,871 Added 3.44%	56,236 $4.33 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $213,607 - $243,365	-2,763 Reduced 4.84%	54,365 $4.51 Million
Q4 2022 Jan 18, 2023	BUY	$62.32 - $89.47 $227,904 - $327,191	3,657 Added 6.84%	57,128 $0
Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $1.6 Million - $1.83 Million	-26,924 Reduced 33.49%	53,471 $3.3 Million
Q2 2022 Jul 13, 2022	BUY	$57.72 - $65.01 $171,659 - $193,339	2,974 Added 3.84%	80,395 $4.97 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $1.17 Million - $1.47 Million	-20,206 Reduced 20.7%	77,421 $4.6 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $2.73 Million - $3.1 Million	-42,110 Reduced 30.14%	97,627 $7.09 Million
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $3.85 Million - $4.16 Million	56,904 Added 68.7%	139,737 $9.76 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $131,002 - $143,138	2,064 Added 2.56%	82,833 $5.7 Million
Q1 2021 Apr 22, 2021	BUY	$60.0 - $68.46 $607,140 - $692,746	10,119 Added 14.32%	80,769 $5.22 Million
Q4 2020 Apr 01, 2021	BUY	$56.65 - $64.55 $801,994 - $913,834	14,157 Added 25.06%	70,650 $4.12 Million
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $452,025 - $568,344	-7,279 Reduced 11.41%	56,493 $3.86 Million
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $479,397 - $556,668	6,627 Added 11.6%	63,772 $4.91 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $1.15 Million - $1.47 Million	18,371 Added 47.38%	57,145 $4.27 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $1.86 Million - $2.05 Million	-30,202 Reduced 43.79%	38,774 $2.52 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $1.26 Million - $1.39 Million	20,199 Added 41.41%	68,976 $4.41 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $355,566 - $398,726	-5,747 Reduced 10.54%	48,777 $3.3 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $118,619 - $132,884	-1,897 Reduced 3.36%	54,524 $3.53 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $844,351 - $1.1 Million	-13,947 Reduced 19.82%	56,421 $3.52 Million
Q3 2018 Nov 01, 2018	BUY	$71.28 - $78.92 $2.33 Million - $2.58 Million	32,681 Added 86.72%	70,368 $5.43 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $1.03 Million - $1.2 Million	-15,834 Reduced 29.58%	37,687 $2.68 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $1.28 Million - $1.57 Million	17,630 Added 49.12%	53,521 $4.04 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $3.57 Million - $4.19 Million	-50,170 Reduced 58.3%	35,891 $2.66 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $378,721 - $448,888	5,252 Added 6.5%	86,061 $7.05 Million
Q2 2017 Aug 10, 2017	BUY	N/A	80,809	80,809 $5.6 Million

Others Institutions Holding GILD

# of Institutions

1,993

Shares Held

993M

Call Options Held

10.1M

Put Options Held

8.85M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Gilead Sciences, Inc. Transaction History